Solid Biosciences's IND For Gene Therapy To Treat Friedreich's Ataxia Gets FDA Clearance
SGT-212 is the company's novel, AAV-based FA gene therapy candidate designed to deliver full-length frataxin via systemic intravenous (IV) infusion as well as direct intradentate nuclei (IDN) infusion ...
Zacks.com on MSN3d
SLDB Stock Up as FDA Clears IND for SGT-212 in Friedreich's Ataxia
Solid Biosciences Inc. SLDB announced that the FDA has cleared its investigational new drug (IND) application to begin ...
dvm3602d
FDA notifies veterinarians of adverse events linked to osteoarthritis treatment
In a recent “Dear Veterinarian” letter, the FDA alerted veterinarians of adverse events in dogs treated with bedinvetmab ...
pharmaphorum3d
Biogen’s Skyclarys is first EU drug for Friedreich’s ataxia
After getting a green light from the European Commission, Biogen’s Skyclarys is the first approved medicine for the inherited neurological disease Friedreich’s ataxia (FA) in the EU.
pharmaphorum6d
CHMP backs Biogen’s Skyclarys for Friedreich’s ataxia
Biogen’s Skyclarys is on course to becoming the first approved medicine for the inherited neurological disease Friedreich’s ataxia (FA) in the EU after it was recommended by the EMA’s human ...
MLB5d
Will Roki be top rookie? It's likely -- but he will have competition
Regardless of which team Roki Sasaki ends up with -- or even which league -- the Japanese phenom will be a strong favorite for Rookie of the Year. Who else has a shot? The MLB Pipeline crew delved ...